PBH Prestige Consumer Healthcare Inc.

$52.53 -0.56%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

Prestige Consumer Healthcare Inc. (PBH) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $2.5 billion. Shares last traded at $52.53, 26.1% below their 52-week high. Over the past year the stock is down 21.5%. PBH trades at a price-to-earnings ratio of 14.47, below the Pharmaceutical Preparations median of 17.31. Net profit margin is 15.6%, above the peer median of -8.9%. Revenue declined 4.3% year over year.

Market Cap

$2.5B

Shares Out

47.4M

EPS (TTM)

$6.15

P/E Ratio

8.54

P/S Ratio

2.25

P/B Ratio

1.30

Dividend / Share

—

Dividend Yield

—

52-Week High

$71.07

52-Week Low

$42.89

Volume

17,036

Avg Vol (3m)

36,993.841

Performance

+2.50%

-0.87%

+15.60%

-22.69%

YTD

-14.22%

-21.48%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

54.35

SMA (50)

$50.64

SMA (200)

$56.83

Price vs SMA50

+3.73%

Price vs SMA200

-7.57%

ATR (14)

$2.31

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$1.1B

Net Income

$172M

Gross Margin

53.5%

Operating Margin

26.3%

Net Margin

15.6%

Return on Equity

9.0%

Return on Assets

3.8%

Current Ratio

3.23

Debt / Equity

1.05

Revenue Growth (YoY)

-4.3%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q1 2027	$0.61	2026-08-06
FY 2026	$3.91	2026-05-14
Q3 2026	$2.78	2026-02-05
Q2 2026	$1.81	2025-11-06
Q1 2027	$0.95	2026-08-06
FY 2026	$4.29	2026-05-14

Full earnings history →

Pharmaceutical Preparations peers

PBH vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

P/E vs peers

14.47 / 17.31 med

-16% discount

P/S vs peers

2.25 / 11.11 med

-80% discount

Net margin vs peers

15.6% / -8.9% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.